Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: Telmisartan

Study type: Observational

Funder types: Industry

Identifiers

NCT02242838

502.500

Details and patient eligibility

About

The primary objective of this survey is to prospectively investigate safety and efficacy in patients with hypertension treated with telmisartan in proper use in medical practice over a long period

Enrollment: 6,336 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with hypertension

Exclusion criteria

Patients with the following conditions

• Patients with a history of hypersensitivity of this product
• Women in pregnancy (included the possibility of pregnancy)
• Patients with severe biliary obstructive disorders or severe hepatic insufficiency

Trial design

6,336 participants in 1 patient group

Hypertensive patients

Treatment:

Drug: Telmisartan